Detecting and categorizing high-grade glioma brain tumors using MRI
Towards MRI-based detection and categorization of invasive high grade glioma subtypes
This study is looking to make it easier for doctors to spot and understand different types of aggressive brain tumors using advanced MRI scans, which could help them plan better treatments and improve outcomes for patients with high-grade gliomas.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-11044555 on NIH RePORTER |
What this research studies
This research aims to improve the detection and classification of invasive high-grade glioma subtypes through advanced MRI techniques. By analyzing the unique microstructure and metabolic profiles of these tumors, the study seeks to identify tumor regions that are currently invisible to standard MRI methods. This could lead to more accurate treatment planning and potentially better outcomes for patients with high-grade gliomas. The research will utilize biopsy samples from patients to correlate imaging findings with tumor biology.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with high-grade gliomas, particularly those with invasive tumor characteristics.
Not a fit: Patients with low-grade gliomas or other types of brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for patients with high-grade gliomas, potentially improving survival rates.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques to better understand tumor biology, indicating that this approach may yield valuable insights.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Beeman, Scott Charles — Arizona State University-Tempe Campus
- Study coordinator: Beeman, Scott Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.